Kathryn B. McKenzie, Chief Accounting Officer at NEOGENOMICS INC (NEO), sold 8,000 shares at $26.37 ($211K) on 2019-12-10, disclosed to the SEC on 2019-12-12.
Open-market sale of $211k NEO by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.